New research moves pramipexole up in the algorithm for treatment resistant depression.

CME: Take the CME Post-Test for this Episode

Published On: 02/23/2026

Duration: 13 minutes, 41 seconds

Chris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We interview Steve Hayes, originator of Acceptance and Commitment Therapy, on the personal struggles that inspired the treatment.

CME: Take the CME Post-Test for this Episode

Published On: 02/16/2026

Duration: 19 minutes, 01 seconds

Chris Aiken, MD, Kellie Newsome, PMHNP, and Steven Hayes, PhD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

An interview with Steve Hayes, originator of Acceptance and Commitment Therapy (ACT), on how his struggle with panic disorder inspired his work. 

CME: Take the CME Post-Test for this Episode

Published On: 02/09/2026

Duration: 20 minutes, 32 seconds

Chris Aiken, MD, and Steven Hayes, PhD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A parent sits across from you and asks, "Why can't my child just take the same anxiety medicine that helps me?” Sounds reasonable, but the evidence tells a very different story.

CME: Take the CME Post-Test for this Episode

Published On: 02/02/2025

Duration: 17 minutes, 53 seconds

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How a new FDA approved device for difficult-to-treat depression engages the brain through the sensory nerves in part II of our interview with Linda Carpenter.

CME: Take the CME Post-Test for this Episode

Published On: 01/26/2026

Duration: 12 minutes, 33 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.

CME: Take the CME Post-Test for this Episode

Published On: 01/19/2026

Duration: 20 minutes, 49 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Marsha Linehan finds the core principles of DBT in a Buddhist monastery, challenges the psychoanalytic establishment, and returns to the hospital where her journey started.

CME: Take the CME Post-Test for this Episode

Published On: 01/12/2026

Duration: 16 minutes, 50 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Marsha Linehan makes it out of a long-term psychiatric hospital and vows to develop a better approach to suicidality, reinventing therapy for borderline personality disorder. 

CME: Take the CME Post-Test for this Episode

Published On: 01/05/2026

Duration: 16 minutes, 50 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How a tip from Carl Jung inspired Alcoholics Anonymous and the 12-step recovery movement. 

CME: Take the CME Post-Test for this Episode

Published On: 12/29/2025

Duration: 08 minutes, 55 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Are psychosis and OCD ever normal? We explore this question from Carl Jung’s breakdown to a new neurologic condition, hyperphantasia.

CME: Take the CME Post-Test for this Episode

Published On: 12/22/2025

Duration: 15 minutes, 41 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.